Welcome to our dedicated page for Adtalem Global Ed SEC filings (Ticker: ATGE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Adtalem Global Education Inc. (NYSE: ATGE), a for-profit operator of colleges, universities, and professional schools with a strong emphasis on healthcare education. As a New York Stock Exchange–listed company, Adtalem files periodic and current reports that offer detailed information on its operations, financial condition, governance, and shareholder-related actions.
Annual reports on Form 10-K and quarterly reports on Form 10-Q contain segment-level data for the Chamberlain, Walden, and Medical and Veterinary segments, along with discussions of enrollment, revenue, operating income, and risk factors. These filings help readers understand how institutions such as Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine contribute to Adtalem’s overall results.
Current reports on Form 8-K document specific material events. Recent 8-K filings have covered the announcement of a new share repurchase authorization of up to $750 million and the completion of a prior $150 million repurchase program, the release of quarterly financial results, the retirement of the president of Chamberlain University, and the adoption of a Rule 10b5-1 trading plan by the company’s chief executive officer. Another 8-K reports the results of Adtalem’s annual meeting of shareholders, including director elections, auditor ratification, and an advisory vote on executive compensation.
Investors can also review Forms 4 and related insider trading disclosures referenced in company communications, which report transactions executed under trading plans such as the disclosed Rule 10b5-1 plan. Together, these filings provide a regulatory record of Adtalem’s financial performance, capital allocation decisions, governance matters, and insider activity.
Stock Titan’s platform enhances these filings with AI-powered summaries that highlight key points from lengthy documents, making it easier to identify segment performance, capital allocation actions, and governance changes without reading every page. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, and Form 4 filings for ATGE are available promptly, while AI-generated explanations help readers interpret complex disclosures in accessible language.
Adtalem Global Education (ATGE) reported insider activity via Form 4. On November 12, 2025, a director received 1,445 restricted stock units (RSUs), with the grant size determined using the $96.86 closing price. These RSUs vest 100% one year after the grant date.
On November 13, 2025, 392 shares were withheld to satisfy tax obligations related to previously granted RSUs at a price of $96.26. After the reported transactions, the director beneficially owned 19,836 shares, held directly.
Adtalem Global Education (ATGE) Form 4: Director Ms. O’Keefe was granted 1,445 restricted stock units representing common stock on 11/12/2025 at a reference price of $96.86. The award vests 100% on the one-year anniversary of the transaction date.
Following the reported grant, beneficial ownership stands at 16,597 shares, held directly. This is a routine director equity award intended to align compensation with shareholder interests.
Adtalem Global Education (ATGE) reported an insider equity award on Form 4. The Chief Corporate Affairs Officer acquired 2,226 shares of common stock on 11/12/2025 coded “A,” reflecting a grant of restricted stock units at a reference price of $96.86 per share.
The award consists of RSUs that convert one-for-one into common stock and vest in three equal installments beginning on November 12, 2026. Following the transaction, the reporting person beneficially owned 2,226 shares, held directly.
Adtalem Global Education (ATGE) Form 4: Lead Independent Director (and Director) reported equity transactions. On 11/12/2025, the reporting person acquired 1,445 shares of common stock in the form of restricted stock units (RSUs) at a reference value of $96.86 per unit, reflecting the closing price used to determine the award size. On 11/13/2025, 526 shares were disposed of to satisfy tax withholding upon vesting at $96.26 per share.
Following these transactions, the reporting person beneficially owns 101,364 shares, held directly. The RSUs vest 100% on the one-year anniversary of the grant date.
Adtalem Global Education (ATGE) reported insider equity activity by its President, Medical and Vet. On 11/12/2025, the officer acquired 2,613 shares reported as restricted stock units (RSUs) at a reported price of $96.86, increasing direct holdings to 13,958 shares. On 11/13/2025, 407 shares were withheld at $96.26 to satisfy taxes upon vesting of prior RSUs, leaving 13,551 shares directly owned.
The filing notes the RSUs convert one-for-one into common stock and vest in three equal installments beginning on November 12, 2026.
Adtalem Global Education (ATGE) director Form 4: A board member reported equity changes tied to director compensation and routine tax withholding. On 11/12/2025, the director received 1,445 restricted stock units at a reference price of $96.86; these stock units vest 100% on the one year anniversary of the transaction date. On 11/13/2025, 421 shares were withheld at $96.26 to satisfy taxes from previously vested awards.
Following these transactions, the director’s direct ownership stands at 16,303 shares.
Adtalem Global Education (ATGE) reported a director’s routine equity transactions on Form 4. On 11/12/2025, the director received 1,445 restricted stock units, determined using the $96.86 closing price, which vest 100% one year from the grant date. On 11/13/2025, 425 shares were withheld to satisfy taxes upon the vesting of earlier RSU awards at a reference price of $96.26.
Following these transactions, the director directly beneficially owns 17,481 shares.
Adtalem Global Education (ATGE): A company director reported Form 4 transactions. On 11/12/2025, the director received 1,445 restricted stock units, which vest 100% one year from the grant date. The grant size was determined using the ATGE closing price of $96.86 on November 12, 2025.
On 11/13/2025, 344 shares were withheld to satisfy tax obligations upon the vesting of previously awarded RSUs at a price of $96.26. Following these transactions, the director reported 8,562 shares directly owned after the grant and 8,218 shares directly owned after the tax withholding.
Adtalem Global Education (ATGE) disclosed an insider equity transaction. The company’s CHRO reported acquiring 1,673 common shares labeled as restricted stock units on 11/12/2025 at a reported price of $96.86. Following this transaction, the officer directly beneficially owns 10,276 shares.
The filing notes these are restricted stock units that convert one-for-one into common stock and vest in three equal installments beginning 11/12/2026.
Adtalem Global Education (ATGE) reported insider activity by its SVP–Chief Marketing Officer. On 11/12/2025, the officer received 1,750 restricted stock units at a stated price of
On 11/13/2025, 343 shares were withheld (Code F) to satisfy taxes upon vesting of previously awarded RSUs at
FAQ
What is the current stock price of Adtalem Global Ed (ATGE)?
What is the market cap of Adtalem Global Ed (ATGE)?
